Skip to content
Disclosery

CAXTON ASSOCIATES LP: ZYME position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of CAXTON ASSOCIATES LP on ZYME, newest first. How the timeline and the estimate are built.

CAXTON ASSOCIATES LP held 0 ZYME shares at 2024-12-31 per its 13F-HR filed 2025-02-14.

the latest 13F is the newest step

  1. period ended2024-12-31
    13F 0 shares
    Change vs previous 13F -45,810 shares

    13F-HR 0000872573-25-000004 filed by CAXTON ASSOCIATES LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

    Exited: the 13F for this period no longer lists the position.

  2. period ended2024-09-30
    13F 45,810 shares
    Change vs previous 13F +45,810 shares

    0.03% of the 13F portfolio, value $574,916.

    13F-HR 0000872573-24-000024 filed by CAXTON ASSOCIATES LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2023-06-30
    13F 0 shares
    Change vs previous 13F -120,772 shares

    13F-HR 0000872573-23-000009 filed by CAXTON ASSOCIATES LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

    Exited: the 13F for this period no longer lists the position.

  4. period ended2023-03-31
    13F 120,772 shares
    Change vs previous 13F not available

    0.17% of the 13F portfolio, value $1,091,779.

    13F-HR 0000899140-23-000644 filed by CAXTON ASSOCIATES LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).